Finding immune markers in blood cell disorders
Part of Blood & lymphatic clinical trials.
This research study looks for specific immune system clues in patients with myeloproliferative neoplasms—rare blood disorders where your bone marrow produces too many blood cells. By identifying these markers, researchers hope to better understand and eventually treat these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with or are suspected to have polycythemia vera (PV), essential thrombocythemia (ET), pre-PMF, primary myelofibrosis (PMF), or an unclassifiable myeloproliferative neoplasm
- You have not been previously diagnosed with any other blood cancer or blood disorder
- You are willing to provide a blood or bone marrow sample for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This observational registry tracks symptoms, treatments, and disease changes over time in people diagnosed with myeloproliferative neoplasms (MPNs). By joining, you help doctors learn more about the condition and possibly contribute to better future care.
This study looks at how pregnancy affects people with myeloproliferative neoplasms (MPNs), which are blood disorders that cause the body to make too many blood cells. It aims to learn more about outcomes for mothers and babies, and how to manage these conditions during pregnancy. You can join if you are pregnant and have an MPN.
This study looks at immune cells (monocytes) in people with certain blood cancers. Researchers want to understand how these cells behave and change over time. You can join if you are newly diagnosed and haven't started treatment yet.
This study looks at whether certain blood cell features can help doctors better understand myeloproliferative neoplasms. By analyzing blood samples, they hope to find new clues that could improve diagnosis and monitoring.
This study looks at heart and blood vessel problems in people with certain blood cancers called myeloproliferative neoplasms (MPNs), including essential thrombocythemia, polycythemia vera, and primary myelofibrosis. It aims to understand how these conditions affect the heart and blood vessels, which may lead to better care.
This is a research registry for people who have certain blood cancers called myeloproliferative neoplasms (MPNs). It helps researchers learn about the disease over time and may help future studies find and compare patients.
Hear when a new Primary Myelofibrosis (PMF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.